Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-01-01 @ 8:39 PM
Study NCT ID:
NCT03987867
Status:
UNKNOWN
Last Update Posted:
2020-07-07
First Post:
2019-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-12
First Submit QC Date:
None
Study First Post Date:
2019-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-05
Last Update Post Date:
2020-07-07
Last Update Post Date Type:
ACTUAL